There are high costs and potential side effects of the new generation of weight loss medications like semaglutide (Wegovy) and tirzepatide (Mounjaro) that are seeing booming demand:
Costs:
- Wegovy costs around $1,300 per month without insurance, while Mounjaro runs $1,000+ monthly
- Even with insurance coverage, out-of-pocket costs can still be hundreds of dollars per month
- The high prices are straining many household budgets and limiting access
Side Effects:
- Common side effects include nausea, diarrhea, vomiting, constipation and stomach pain
- More serious risks like pancreatitis, gallbladder issues and vision problems can occur
- Effects on cardiovascular health, kidney function still being studied
The medications’ impressive weight loss results are driving their popularity despite the expenses and side effect risks. However, experts caution the drugs should be combined with dietary and lifestyle changes for maximum long-term benefit.
Insurance coverage policies remain inconsistent, with some plans covering the drugs only for diabetes currently. Advocacy groups are pushing for expanded affordable access for obesity treatment.
While exciting, the high costs and side effect profiles mean the weight loss drugs may not be suited or accessible for many patients who could potentially benefit. More affordable options are still needed.
